User:NKuldell/Q/A working reference list: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
*Sci Am Fab group | *Sci Am Fab group | ||
*Pam's G&D paper | *Pam's G&D paper | ||
**Voight,Keasling Nat Chem Biol. 2005 Nov;1(6):304-7 | |||
*[http://www.bioinfo.de/isb/2006/06/0038/] | *[http://www.bioinfo.de/isb/2006/06/0038/] | ||
| Line 16: | Line 17: | ||
===from Part1, Q3=== | ===from Part1, Q3=== | ||
add [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=16330045&query_hl=4&itool=pubmed_docsum] | |||
<biblio> | <biblio> | ||
#Chan-MSB-2005 pmid=16729053 | #Chan-MSB-2005 pmid=16729053 | ||
Revision as of 02:37, 29 August 2006
Running reference list: incomplete and unorganized
from Part 1, Q2
- Sci Am Fab group
- Pam's G&D paper
- Voight,Keasling Nat Chem Biol. 2005 Nov;1(6):304-7
- [1]
Reviews that focus on implications of the technology are
- Synthetic Biologists face up to security risks Nature 436, 894-895 (18 Aug 2005) News File:Presentation material-synthbiolrisks Nat05.pdf
- From Understanding to Action: Community-Based Options for Improving Safety and Security in Synthetic Biology, Stephen M. Maurer, Keith V. Lucas & Starr Terrell, Goldman School of Public Policy, University of California at Berkeley PDF link
- Draft Declaration of the Second International Meeting on Synthetic Biology, Attendees of SB2.0, University of California at Berkeley, May 2006. pdf article
- (AJ) Bhutkar's article in The Journal of Biolaw & Business analyzing patentability, ethical and regulatory challenges in Synthetic Biology.
Reviews in the lay press include
- Tucker & Zilinskas, The New Atlantis, Spring 2006 link
- Custom-Made Microbes, at Your Service by A Pollack NYT Science section January 17, 2006 link
from Part1, Q3
add [2]
- Chan LY, Kosuri S, and Endy D. Refactoring bacteriophage T7. Mol Syst Biol. 2005;1:2005.0018. DOI:10.1038/msb4100025 |
- Itaya M, Tsuge K, Koizumi M, and Fujita K. Combining two genomes in one cell: stable cloning of the Synechocystis PCC6803 genome in the Bacillus subtilis 168 genome. Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):15971-6. DOI:10.1073/pnas.0503868102 |
- Pósfai G, Plunkett G 3rd, Fehér T, Frisch D, Keil GM, Umenhoffer K, Kolisnychenko V, Stahl B, Sharma SS, de Arruda M, Burland V, Harcum SW, and Blattner FR. Emergent properties of reduced-genome Escherichia coli. Science. 2006 May 19;312(5776):1044-6. DOI:10.1126/science.1126439 |
- Ro DK, Paradise EM, Ouellet M, Fisher KJ, Newman KL, Ndungu JM, Ho KA, Eachus RA, Ham TS, Kirby J, Chang MC, Withers ST, Shiba Y, Sarpong R, and Keasling JD. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature. 2006 Apr 13;440(7086):940-3. DOI:10.1038/nature04640 |
- Giesecke AV, Fang R, and Joung JK. Synthetic protein-protein interaction domains created by shuffling Cys2His2 zinc-fingers. Mol Syst Biol. 2006;2:2006.2011. DOI:10.1038/msb4100053 |
- Chen IA, Salehi-Ashtiani K, and Szostak JW. RNA catalysis in model protocell vesicles. J Am Chem Soc. 2005 Sep 28;127(38):13213-9. DOI:10.1021/ja051784p |
